The portfolio maintains a sizable cost advantage over competitors, priced within the lowest fee quintile among peers.
First Trust NYSE Arca Biotech ETF FBT
Morningstar’s Analysis FBT
Will FBT outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 35.0
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Alkermes PLC | 3.86 | 44.5 Mil | Healthcare |
Corcept Therapeutics Inc | 3.59 | 41.4 Mil | Healthcare |
Gilead Sciences Inc | 3.55 | 40.9 Mil | Healthcare |
Incyte Corp | 3.49 | 40.3 Mil | Healthcare |
BeiGene Ltd ADR | 3.48 | 40.2 Mil | Healthcare |
Halozyme Therapeutics Inc | 3.41 | 39.4 Mil | Healthcare |
Repligen Corp | 3.41 | 39.4 Mil | Healthcare |
Catalyst Pharmaceuticals Inc | 3.40 | 39.2 Mil | Healthcare |
United Therapeutics Corp | 3.40 | 39.2 Mil | Healthcare |
ACADIA Pharmaceuticals Inc | 3.39 | 39.1 Mil | Healthcare |